WHO halts trial of hydroxychloroquine in COVID-19 patients
Reuters India -

The World Health Organization said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit.

Read this story at , ,


Related Articles